10x Genomics, Inc.

TXG

Precision medicineBiotech & pharmaceuticalsGenomic analysis

$80.65vs prev close▲+3.37(+4.36%)

$11.1652W Range$102.81

76% from low

+13.44 (+19.67%)Past 1M

Price

ARK Trade PatternPREMIUM

1M Trades

9 sells

Consecutive sells

1M net buy

-$96.6M

≈ -1.2M shares

Portfolio Weight

3.45%

1M +0.61%p

Holding ETFs

2 ETFs

ARKG · ARKK

Natural Weight Increase

No trades in this period; price appreciation alone increased the weight.

Shares +0.5% · Market value +55.3% · Weight +0.61%p

Trade Intensity

Consecutive sells 9

Basis: 9 sells · 0 buys in 1M · Multi-ETF simultaneous sell · weight +0.61%p increase

Trade Log9-day SELL streak

Date	Action	ETF	Shares	Close	Est. total
26.10.08	SELL	ARKK	237,109	$77.28	$18.3M
26.10.06	SELL	ARKG · ARKK	23,503	$80.66	$1.9M
26.10.05	SELL	ARKG	27,277	$97.74	$2.7M
26.10.02	SELL	ARKG	12,115	$93.50	$1.1M
26.09.29	SELL	ARKG · ARKK	435,394	$90.04	$39.2M
26.09.22	SELL	ARKG	49,651	$80.70	$4.0M
26.09.21	SELL	ARKG	32,284	$79.10	$2.6M
26.09.14	SELL	ARKG · ARKK	322,723	$70.11	$22.6M
26.09.11	SELL	ARKK	60,556	$68.59	$4.2M
26.09.08	SELL	ARKG	46,401	$65.60	$3.0M
26.08.31	SELL	ARKG	49,811	$62.45	$3.1M
26.08.21	SELL	ARKK	10,033	$65.12	$653.3K
26.08.20	SELL	ARKK	65,922	$63.87	$4.2M
26.08.19	SELL	ARKG · ARKK	203,242	$62.19	$12.6M
26.08.18	SELL	ARKG · ARKK	36,478	$55.63	$2.0M

10.08SELL

237,109

ARKKClose$77.28Est. total$18.3M

10.06SELL

23,503

ARKG · ARKKClose$80.66Est. total$1.9M

10.05SELL

27,277

ARKGClose$97.74Est. total$2.7M

10.02SELL

12,115

ARKGClose$93.50Est. total$1.1M

09.29SELL

435,394

ARKG · ARKKClose$90.04Est. total$39.2M

09.22SELL

49,651

ARKGClose$80.70Est. total$4.0M

09.21SELL

32,284

ARKGClose$79.10Est. total$2.6M

09.14SELL

322,723

ARKG · ARKKClose$70.11Est. total$22.6M

09.11SELL

60,556

ARKKClose$68.59Est. total$4.2M

09.08SELL

46,401

ARKGClose$65.60Est. total$3.0M

08.31SELL

49,811

ARKGClose$62.45Est. total$3.1M

08.21SELL

10,033

ARKKClose$65.12Est. total$653.3K

08.20SELL

65,922

ARKKClose$63.87Est. total$4.2M

08.19SELL

203,242

ARKG · ARKKClose$62.19Est. total$12.6M

08.18SELL

36,478

ARKG · ARKKClose$55.63Est. total$2.0M

1 / 15

Prices estimated from market closing prices on trade dates. Actual execution prices may differ. This is not investment advice.

Stock Timeline

Institutional Holders

2 Holding · 0 Sold · Q4 2025

Based on ARK ETF real-time + 13F quarterly filings

Cathie WoodARK Invest

LIVE

6,104,363

Portfolio Weight

3.45%

in ETF 10.23%

Est. Value

$597M

30D Net

-$100M

Ray DalioBridgewater Associates

New Buy

177,734

Portfolio Weight

0.01%

Est. Value

$3M

Change

New position

13F data may be delayed up to 90 days.

Market Context

Analyst Consensus

※ Analyst opinions are for reference only and do not constitute investment advice. Each securities firm may have different opinions.

Overall Opinion

Buy

Strong Buy

Buy

Hold

Analyst Targets

avg.

$69.47

vs Current ▼ -13.9% downside

Current$80.65

Low ~ High$40.00 ~ $110.00

Firm

Position

Price Target

Upside / Downside

Close Price

Action

Date

Barclays

Overweight

$110.00

+36.39%

—

Maintain

2026-10-07

Leerink Partners

Market Perform

$90.00

+11.59%

—

Maintain

2026-09-29

Piper Sandler

Neutral

$80.00

-0.81%

—

Maintain

2026-09-28

Argus Research

Buy

$110.00

+36.39%

—

Upgrade

2026-09-28

UBS

Neutral

$68.00

-15.69%

—

Maintain

2026-09-09

1 / 4

Avg Target

$69.47

vs Current ▼ -13.9% downside

Buy

19 analysts

Strong Buy 1Buy 6Hold 12

Low $40.00

Current $80.65

High $110.00

Firm	Position	Target	Upside	Close	Action	Date
Barclays	Overweight	$110.00	+36.39%	—	Maintain	26.10.07
Leerink Partners	Market Perform	$90.00	+11.59%	—	Maintain	26.09.29
Piper Sandler	Neutral	$80.00	-0.81%	—	Maintain	26.09.28
Argus Research	Buy	$110.00	+36.39%	—	Upgrade	26.09.28
UBS	Neutral	$68.00	-15.69%	—	Maintain	26.09.09

1 / 4

Price Information

Previous Close$77.28

Open$79.16

Day Range$79.16 - $85.12

52-Week Range$11.16 - $102.81

1-Year Change595.26%

Trading Volume

Volume3,684,561

Avg Volume (3mo)3,303,220

Valuation

Market Cap10.5B

Book Value$6.34

Shares Outstanding120,212,296

Financials

Revenue (TTM)616.9M

Net Income-75,125,000

EPS$-0.59

EBITDA-41,201,000

Profitability

P/E Ratio-

P/B Ratio12.73

Return on Equity (ROE)-9.40%

Return on Assets (ROA)-5.05%

Profit Margin-12.18%

EV/EBITDA-243.56

Beta1.99

Dividend

Dividend Rate-

Dividend Yield0.00%

Technical

RSI(14)51.33

Company Overview

10x Genomics is a life science technology company that provides instruments, consumables, and software for analyzing biological systems. Their main products include the Chromium platform for single-cell analysis and the Visium and Xenium platforms for spatial analysis of genes and proteins within tissues. They serve a global market of academic, government, and industry research institutions.

P/B

12.73

High valuation

ROE

-9.4%

Net loss

Beta

1.99

High volatility

RSI(14)

51.3

Neutral

AI-generated summary. Not investment advice.

10x Genomics, Inc.

Analyst Consensus

Price Information

Trading Volume

Valuation

Financials

Profitability

Dividend

Technical

Related ARK stocks